The therapeutic use of antibodies for malignancy

Author： Johnson P.W.M.  

Publisher： Elsevier

ISSN： 1246-7820

Source： Transfusion Clinique et Biologique, Vol.8, Iss.3, 2001-06, pp. : 255-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Antibodies

By  

Current Molecular Medicine, Vol. 4, Iss. 5, 2004-08 ,pp. : 539-547

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Immunoglobulins for Therapeutic Use Contain Anti-idiotypes against Xenophile Antibodies and Prolong Discordant Graft Survival

By Schussler O.   Genevaz D.   Latremouille C.   Goussev N.   Kaveri S.   Glotz D.  

Clinical Immunology, Vol. 86, Iss. 2, 1998-02 ,pp. : 183-191

Academic Press

Access to resources Recommend Favorite

The Proteasome: A Novel Therapeutic Target in Haematopoietic Malignancy

By Magill Laura   Walker Brian   Irvine Alexandra E.  

Hematology, Vol. 8, Iss. 5, 2003-10 ,pp. : 275-283

Maney Publishing

Access to resources Recommend Favorite

Exploiting antibodies as catalysts: potential therapeutic applications

By Tellier C.  

Transfusion Clinique et Biologique, Vol. 9, Iss. 1, 2002-01 ,pp. : 1-8

Elsevier

Access to resources Recommend Favorite

Therapeutic Use of Limbal Stem Cells

By  

Current Stem Cell Research & Therapy, Vol. 1, Iss. 2, 2006-05 ,pp. : 231-238

Bentham Science Publishers

Access to resources Recommend Favorite